Jubilant pharmova has been trading in a big range since last few years.
Stock has managed to close above the resistance and has also retested the breakout.
Stock has potential to fly from this levels.

Keep stock in watchlist. A nifty500 stock and hence can be relatively safer option.
Not a recommendation.
chartanalysisdarvasboxjubilantpharmanifty500PHARMARectanglestrongbreakoutSupply and Demandweeklybreakout

يعمل أيضًا:

إخلاء المسؤولية